News & Perspective

Feb 12, 2019

Feb 12, 2019

News Scan for Feb 12, 2019

More Saudi MERS cases
Yellow fever in Brazil
Lassa fever in Guinea and Nigeria
Zika in Mexico
Gain-of-function H5N1 studies to resume

Apr 03, 2019

Apr 03, 2019
Community Ebola representatives in DR Congo

DRC Ebola total hits 1,100; study targets secondary spread

Admission to an Ebola treatment unit was tied to a 38% drop in secondary cases.

Aug 28, 2014

Aug 28, 2014

Ebola Scan for Aug 28, 2014

Ebola vaccine gains steam
Clinical lessons from US patients

May 02, 2014

May 02, 2014

News Scan for May 02, 2014

More MERS-CoV antibodies
Ebola in Guinea
Renamed biodefense board
Universal flu vaccine

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Nov 04, 2015

Nov 04, 2015
Ebola baby

Newborn's Ebola infection adds to Guinea's total

The child's case is the 4th—including a death—from the same family in Forecariah district.

Jul 15, 2015

Jul 15, 2015
Freetown street scene

Ebola activity steady, back in Guinea and Sierra Leone capitals

Also, phase 2 trials just launched for two prime-boost Ebola vaccine regimens.

Mar 31, 2015

Mar 31, 2015
Lab worker with test tubes

BioCryst gets HHS contract for Ebola drug development

Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.

Mar 27, 2015

Mar 27, 2015
Syringe on vials

Two Ebola vaccines shown safe as next step pondered

The findings clear the way for the next step, which may require a change in venue.

Mar 26, 2015

Mar 26, 2015
Ebola virus

Gene study finds no worrisome changes in Ebola virus

The virus may be more stable than a study in August found.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»